Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
Kubes P, Mehal WZ
For patients taking GLP-1 receptor agonists such as semaglutide or dulaglutide, there is currently no evidence suggesting that allulose interferes with medication efficacy or causes adverse interactions
in Spain, its current prevalence ranges between 2833%11,12 and it is a recognized as a cardiovascular risk factor and increases the mortality in this population.1315 Furthermore, in patients with DM2 and advanced CKD there are limitations in the prescription of certain antihyperglycemic drugs (e.g., metformin or sulfonylureas) and there is an increased risk of hypoglycemia with antihyperglycemic treatment,16 a complication that is associated with increased cardiovascular risk17 and hinders the achievement of glycemic control targets
MASH develops when fat accumulates in the liver
It has even been found to be an effective treatment for carpal tunnel syndrome
US$ 25.56
US$ 23.29
US$ 24.59
US$ 23.86
